Envestnet Asset Management Inc Harmony Biosciences Holdings, Inc. Transaction History
Envestnet Asset Management Inc
- $326 Billion
- Q2 2025
A detailed history of Envestnet Asset Management Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 42,385 shares of HRMY stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,385
Previous 58,329
27.33%
Holding current value
$1.1 Million
Previous $1.94 Million
30.8%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HRMY
# of Institutions
287Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$172 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$133 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$42.3 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$41.1 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.54B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...